DJIA 18,132.70 -81.72 -0.45%
NASDAQ 4,963.53 -24.36 -0.49%
S&P 500 2,104.50 -6.24 -0.30%
market minute promo

Hospira, Inc. (NYSE: HSP)

87.54 0.00 (0.00%)

REAL-TIME: Last trade at


company name or ticker

Recent Quotes

HSP $87.54 0.00%
Company Photos
(Click to zoom)
1D 1W 3M 6M 1Y 2Y 3Y
Today's Open $87.49
Previous Close $87.54
Daily Range $87.47 - $87.55
52-Week Range $40.41 - $87.77
Market Cap $15.0B
P/E Ratio 44.89
Dividend (Yield) $0.00 (0.0%)
Volume 2,697,748
Average Daily Volume 4,359,348
Current FY EPS $2.40

Sector

Healthcare

Industry

Drug Makers

Hospira, Inc. (HSP) Description

A specialty pharmaceutical and medication delivery company that is focused on products that improve the productivity, safety and efficacy of patient care. Website: http://www.hospira.com/

News & Commentary Rss Feed

Pssst... Pfizer Just Told Investors That This is the Next Big Thing

Pfizer Inc.'s acquisition of Hospira could signal that investors should embrace biosimilar drugmakers.

Why I Believe Pfenex Is A Strong Buy

Volatility Index signals that the bull has room to run

Pfizer Rapamune Under FDA Priority Review for Lung Disease - Analyst Blog

Valeant Pharmaceuticals Buys Salix Pharmaceuticals in $14.5 Billion Megadeal

$20 Billion Market: What’s the Best Stock to Buy?

Three drug companies to watch as biologics come off patent and investors anticipate a biosimilar boom -- here's what you need to know.

Hot Dividend Stocks: Pfizer Pulls Back Into Buy Range

The Medicines Co. Earnings Down Y/Y, Angiomax Sales Grow - Analyst Blog

Hospira's Q4 Earnings Were Bright, Though Acquisition Is In The Cards

Hospira Launches Inflectra, Remicade Biosimilar, in Europe - Analyst Blog

Hospira Launches Inflectra, Remicade Biosimilar, in Europe - Analyst Blog

See More HSP News...

HSP's Top Competitors

HSP $87.54 (0.00%)
Current stock: HSP
$0.00 (0.00%)
Current stock:
MDT $77.59 (-1.55%)
Current stock: MDT
COV $108.06 (0.00%)
Current stock: COV